(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Health care stocks continued to add their Wednesday advance, with the NYSE Health Care Index and the SPDR Health Care Select Sector ETF (XLV) rising 1.9%...
(Updates with share price in the headline and last paragraph) Rhythm Pharmaceuticals (RYTM) said Wednesday it has modified phase 2 and 3 trials evaluating...
Health care stocks were mostly higher this afternoon, with the NYSE Health Care Index and the SPDR Health Care Select Sector ETF (XLV) both rising 1.0%. ...
Rhythm Pharmaceuticals (RYTM) said Wednesday it has modified phase 2 and 3 trials evaluating its setmelanotide medicine for rare genetic diseases of...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Rhythm Pharmaceuticals (RYTM) said Thursday the US Food and Drug Administration extended the review period for the supplemental new drug application for...
Rhythm Pharmaceuticals (RYTM) shares were up 16% in Thursday afternoon trading after Ladenburg Thalmann upgraded the biopharmaceutical company's stock to...
Rhythm Pharmaceuticals (RYTM) has an average rating of outperform and price targets ranging from $10 to $50, according to analysts polled by Capital IQ....